Found 39 matching trials
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Show More Location
Federico II University Medical School
Learn More & Join Trial
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer PHASE2 Primary Objective:
To determine whether amcenestrant per overall survival ...
Show More Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Learn More & Join Trial
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer PHASE4 The main purpose of this study is to learn more about the safety and tolera...
Show More Location
MNJ Institute of Oncology
Learn More & Join Trial
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors PHASE1 The main purpose of this study is to learn more about the safety, side effe...
Show More Location
Mayo Clinic of Scottsdale
Learn More & Join Trial
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer PHASE3 Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Show More Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Learn More & Join Trial
Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial PHASE2 Purpose: This study aimed to analyze changes in serum estradiol (E2) levels...
Show More Location
HUS Comprehensive Cancer Center
Learn More & Join Trial
SNF Platform Study of HR+/ HER2-advanced Breast Cancer PHASE2 The purpose of this study is to establish a prospective, multi-center platf...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer PHASE2 This phase II, multicenter, open-label, randomized controlled trial (FACET ...
Show More Location
Multiple Locations
Learn More & Join Trial
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer PHASE2 To compare continuing bevacizumab + paclitaxel or switching to bevacizumab ...
Show More Location
Japan Breast Cancer Research Group
Learn More & Join Trial
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men PHASE1 Aromatase inhibition versus estradiol during 1 week...
Location
University Hospital Ghent
Learn More & Join Trial